# Develop Health

> Develop Health is a San Francisco Bay Area healthtech company building AI that removes the paperwork between a doctor writing a prescription and a patient actually getting it. Its EHR-integrated platform uses more than a dozen purpose-built large language model pipelines to verify insurance coverage in real time, assemble and submit the correct prior authorization package, track status, and draft appeals for denials - work that normally consumes hours of a care team's day. Founded in 2022 by former Canvas Medical and Rupa Health operators, the company raised a $14.3M Series A in August 2025 and says it cuts medication-access admin work by roughly 83% while supporting hundreds of thousands of patients a month.

- **Founded:** 2022
- **Headquarters:** Menlo Park, California, United States
- **Founders:** Mel van Londen (Co-Founder & CEO), Benjamin Easton (Co-Founder & CTO)
- **Team size:** ~24 employees
- **Products:** Prior Authorization Automation, Real-Time Benefit Verification, Denial Management & Appeals
- **Notable:** Raised $14.3M Series A led by Wing Venture Capital in August 2025 (total funding ~$17.6M)., Describes itself as the first medication-access platform fully architected around generative AI., Reports reducing medication-access administrative work by ~83% and cutting approval times from about a week to under a day.

## Products & services

- **Prior Authorization Automation** — AI that reads the patient chart in the EHR, selects the correct payer form, drafts and submits the prior authorization package, and continuously tracks status - returning structured data back into the provider's system.
- **Real-Time Benefit Verification** — Checks a patient's insurance coverage, cost, and prior-auth requirements in real time, before a prescription is written, so care teams know what's covered up front.
- **Denial Management & Appeals** — Reviews denials, suggests care-plan modifications to improve approval odds, and independently drafts and submits appeals.

## Achievements

- Raised $14.3M Series A led by Wing Venture Capital in August 2025 (total funding ~$17.6M).
- Describes itself as the first medication-access platform fully architected around generative AI.
- Reports reducing medication-access administrative work by ~83% and cutting approval times from about a week to under a day.
- Supports hundreds of thousands of patients per month with a ~24-person team.
- Signed digital health leaders including Ro, LifeMD, and Sunrise as customers.

## Latest updates

- **2025-08** — Closed a $14.3M Series A led by Wing Venture Capital to automate prior authorization and medication access with GenAI.
- **2025-08** — Announced plans to expand beyond medication access into the medical benefit space, including labs and imaging.

## Links

- Website: https://develophealth.ai
- LinkedIn: https://www.linkedin.com/company/develop-health

---

Profile page: https://yespress.io/develop-health
Published by YesPress — https://yespress.io
Last updated: 2026-07-12